What does Onconetix, Inc. do?
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a…
What is Onconetix, Inc.'s P/E and P/B ratio?
Onconetix, Inc. has a P/E ratio of 0.0 and a P/B ratio of 0.16.
What is Onconetix, Inc.'s debt-to-equity ratio?
Onconetix, Inc. has a debt-to-equity ratio of 0.01.
How much does Onconetix, Inc. owe compared with what it owns?
Onconetix, Inc. owes $0.18 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Onconetix, Inc.'s Positivity rank?
Onconetix, Inc. is ranked #42 of 6,774 companies globally and #13 of 4,000 in United States on PositoAI, with a Positivity Score of 25,902.
Does Onconetix, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Onconetix, Inc..
Where can I read the latest news about Onconetix, Inc.?
Recent headlines about Onconetix, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Onconetix, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Onconetix, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.